Advertisement
Screener

enVVeno Medical Corp (NVNO) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

enVVeno Medical Corp Stock-Based Compensation

enVVeno Medical Corp (NVNO) reported Stock-Based Compensation of $864.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-07-30

  • enVVeno Medical Corp share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $397.00K, a 72.51% decline year-over-year.
  • enVVeno Medical Corp share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $467.00K, a 28.26% decline year-over-year.
  • enVVeno Medical Corp share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $637.00K, a 37.43% decline year-over-year.
  • enVVeno Medical Corp share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $688.00K, a 31.41% decline year-over-year.
  • enVVeno Medical Corp share-based payment arrangement, noncash expense for fiscal 2025 was $3.42M, a 17.41% decline from fiscal 2024.
  • enVVeno Medical Corp share-based payment arrangement, noncash expense for fiscal 2024 was $4.14M, a 20.30% decline from fiscal 2023.
  • enVVeno Medical Corp share-based payment arrangement, noncash expense for fiscal 2023 was $5.20M, a 42.23% decline from fiscal 2022.
  • enVVeno Medical Corp share-based payment arrangement, noncash expense for fiscal 2022 was $8.99M, a 49.92% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$397.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$864.00K
10-Q · filed 2026-07-30
$1.50M
derived: sum of 3 quarters · filed 2026-07-30
$2.19M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$467.00K
10-Q · filed 2026-05-06
$1.10M
derived: sum of 2 quarters · filed 2026-05-06
$1.79M
derived: sum of 3 quarters · filed 2026-05-06
$3.24M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$637.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$1.32M
derived: sum of 2 quarters · filed 2026-03-26
$2.77M
derived: sum of 3 quarters · filed 2026-07-30
$3.42M
10-K · filed 2026-03-26
2025-09-30$688.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$2.13M
derived: sum of 2 quarters · filed 2026-07-30
$2.78M
10-Q · filed 2025-10-30
$3.80M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$1.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$2.10M
10-Q · filed 2026-07-30
$3.11M
derived: sum of 3 quarters · filed 2026-07-30
$4.12M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$651.00K
10-Q · filed 2026-05-06
$1.67M
derived: sum of 2 quarters · filed 2026-05-06
$2.67M
derived: sum of 3 quarters · filed 2026-05-06
$3.68M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$2.02M
derived: sum of 2 quarters · filed 2026-03-26
$3.03M
derived: sum of 3 quarters · filed 2026-03-26
$4.14M
10-K · filed 2026-03-26
2024-09-30$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$2.01M
derived: sum of 2 quarters · filed 2025-10-30
$3.12M
10-Q · filed 2025-10-30
$4.27M
derived: sum of 4 quarters · filed 2025-10-30
2024-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$2.12M
10-Q · filed 2025-07-31
$3.26M
derived: sum of 3 quarters · filed 2025-07-31
$4.37M
derived: sum of 4 quarters · filed 2025-07-31
2024-03-31$1.11M
10-Q · filed 2025-04-30
$2.26M
derived: sum of 2 quarters · filed 2025-04-30
$3.36M
derived: sum of 3 quarters · filed 2025-04-30
$4.52M
derived: sum of 4 quarters · filed 2025-04-30
2023-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$2.25M
derived: sum of 2 quarters · filed 2025-02-28
$3.40M
derived: sum of 3 quarters · filed 2025-02-28
$5.20M
10-K · filed 2025-02-28
2023-09-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$2.26M
derived: sum of 2 quarters · filed 2024-10-31
$4.05M
10-Q · filed 2024-10-31
$6.29M
derived: sum of 4 quarters · filed 2024-10-31
2023-06-30$1.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
$2.95M
10-Q · filed 2024-07-31
$5.19M
derived: sum of 3 quarters · filed 2024-07-31
$7.40M
derived: sum of 4 quarters · filed 2024-07-31
2023-03-31$1.79M
10-Q · filed 2024-05-08
$4.03M
derived: sum of 2 quarters · filed 2024-05-08
$6.24M
derived: sum of 3 quarters · filed 2024-05-08
$8.54M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$4.45M
derived: sum of 2 quarters · filed 2024-02-29
$6.75M
derived: sum of 3 quarters · filed 2024-02-29
$8.99M
10-K · filed 2024-02-29
2022-09-30$2.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26
$4.51M
derived: sum of 2 quarters · filed 2023-10-26
$6.76M
10-Q · filed 2023-10-26
$12.10M
derived: sum of 4 quarters · filed 2023-10-26
2022-06-30$2.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31
$4.55M
10-Q · filed 2023-07-31
$4.48M
10-Q · filed 2022-08-03
$9.89M
derived: sum of 3 quarters · filed 2023-07-31
$10.21M
derived: sum of 4 quarters · filed 2023-07-31
2022-03-31$2.24M
10-Q · filed 2023-04-28
$7.59M
derived: sum of 2 quarters · filed 2023-04-28
$7.91M
derived: sum of 3 quarters · filed 2023-04-28
$8.11M
derived: sum of 4 quarters · filed 2023-04-28
2021-12-31$5.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$5.67M
derived: sum of 2 quarters · filed 2023-03-02
$5.87M
derived: sum of 3 quarters · filed 2023-03-02
$6.00M
10-K · filed 2023-03-02
$6.00M
10-K · filed 2022-03-28
2021-09-30$325.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
$527.00K
derived: sum of 2 quarters · filed 2022-10-27
$656.00K
10-Q · filed 2022-10-27
$656.28K
10-Q · filed 2021-11-12
$1.17M
derived: sum of 4 quarters · filed 2022-10-27
2021-06-30$202.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$331.00K
10-Q · filed 2022-08-03
$331.28K
10-Q · filed 2021-08-11
$849.19K
derived: sum of 3 quarters · filed 2022-08-03
$1.04M
derived: sum of 4 quarters · filed 2022-08-03
2021-03-31$129.00K
10-Q · filed 2022-04-29
$129.16K
10-Q · filed 2021-05-12
$647.19K
derived: sum of 2 quarters · filed 2022-04-29
$841.61K
derived: sum of 3 quarters · filed 2022-04-29
$879.32K
derived: sum of 4 quarters · filed 2022-04-29
2020-12-31$518.19K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28
$712.61K
derived: sum of 2 quarters · filed 2022-03-28
$750.32K
derived: sum of 3 quarters · filed 2022-03-28
$881.21K
10-K · filed 2022-03-28
$693.11K
10-K · filed 2021-03-31
2020-09-30$194.42K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$232.14K
derived: sum of 2 quarters · filed 2021-11-12
$363.03K
10-Q · filed 2021-11-12
$559.72K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$37.72K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$168.61K
10-Q · filed 2021-08-11
$365.30K
derived: sum of 3 quarters · filed 2021-08-11
$559.23K
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$130.89K
10-Q · filed 2021-05-12
$327.58K
derived: sum of 2 quarters · filed 2021-05-12
$521.51K
derived: sum of 3 quarters · filed 2021-05-12
$968.54K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$196.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
$390.62K
derived: sum of 2 quarters · filed 2021-03-31
$837.65K
derived: sum of 3 quarters · filed 2021-03-31
$941.96K
10-K · filed 2021-03-31
$941.96K
10-K · filed 2020-03-18
2019-09-30$193.93K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17
$640.96K
derived: sum of 2 quarters · filed 2020-11-17
$745.27K
10-Q · filed 2020-11-17
$1.02M
derived: sum of 4 quarters · filed 2020-11-17
2019-06-30$447.03K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$551.34K
10-Q · filed 2020-08-14
$826.99K
derived: sum of 3 quarters · filed 2020-08-14
$1.21M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$104.31K
10-Q · filed 2020-06-08
$379.96K
derived: sum of 2 quarters · filed 2020-06-08
$767.65K
derived: sum of 3 quarters · filed 2020-06-08
$1.89M
derived: sum of 4 quarters · filed 2020-06-08
2018-12-31$275.65K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-18
$663.34K
derived: sum of 2 quarters · filed 2020-03-18
$1.79M
derived: sum of 3 quarters · filed 2020-03-18
$1.92M
10-K · filed 2020-03-18
2018-09-30$387.69K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$1.51M
derived: sum of 2 quarters · filed 2019-10-31
$1.65M
10-Q · filed 2019-10-31
$1.80M
derived: sum of 4 quarters · filed 2019-10-31
2018-06-30$1.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05
$1.26M
10-Q · filed 2019-08-05
$1.41M
derived: sum of 3 quarters · filed 2019-08-05
$1.86M
derived: sum of 4 quarters · filed 2019-08-05
2018-03-31$137.38K
10-Q · filed 2019-05-09
$291.67K
derived: sum of 2 quarters · filed 2019-05-09
$741.03K
derived: sum of 3 quarters · filed 2019-05-09
2017-12-31$154.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$603.65K
derived: sum of 2 quarters · filed 2019-03-14
$878.40K
10-K · filed 2019-03-14
2017-09-30$449.36K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$724.11K
10-Q · filed 2018-11-07
2017-06-30$274.75K
10-Q · filed 2018-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26